Xeno Transplants Corp (XENO)
0.0001
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
Xeno Transplants Max Drawdown (5Y): 100.00% for Sept. 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
September 30, 2024 | 100.00% |
August 31, 2024 | 100.00% |
July 31, 2024 | 100.00% |
June 30, 2024 | 100.00% |
May 31, 2024 | 100.00% |
April 30, 2024 | 100.00% |
March 31, 2024 | 100.00% |
February 29, 2024 | 100.00% |
January 31, 2024 | 100.00% |
December 31, 2023 | 100.00% |
November 30, 2023 | 100.00% |
October 31, 2023 | 100.00% |
September 30, 2023 | 100.00% |
August 31, 2023 | 100.00% |
July 31, 2023 | 100.00% |
June 30, 2023 | 100.00% |
May 31, 2023 | 100.00% |
April 30, 2023 | 100.00% |
March 31, 2023 | 100.00% |
February 28, 2023 | 100.00% |
January 31, 2023 | 100.00% |
December 31, 2022 | 100.00% |
November 30, 2022 | 100.00% |
October 31, 2022 | 100.00% |
September 30, 2022 | 100.00% |
Date | Value |
---|---|
August 31, 2022 | 100.00% |
July 31, 2022 | 100.00% |
June 30, 2022 | 100.00% |
May 31, 2022 | 100.00% |
April 30, 2022 | 100.00% |
March 31, 2022 | 100.00% |
February 28, 2022 | 100.00% |
January 31, 2022 | 100.00% |
December 31, 2021 | 100.00% |
November 30, 2021 | 100.00% |
October 31, 2021 | 100.00% |
September 30, 2021 | 99.76% |
August 31, 2021 | 99.76% |
July 31, 2021 | 99.51% |
June 30, 2021 | 98.33% |
May 31, 2021 | 98.33% |
April 30, 2021 | 98.33% |
March 31, 2021 | 98.33% |
February 28, 2021 | 98.33% |
January 31, 2021 | 98.33% |
December 31, 2020 | 98.33% |
November 30, 2020 | 91.67% |
October 31, 2020 | 90.45% |
September 30, 2020 | 90.45% |
August 31, 2020 | 90.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
90.45%
Minimum
Jan 2020
100.00%
Maximum
Oct 2021
97.74%
Average
100.00%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
Ampio Pharmaceuticals Inc | 100.0% |
FluoroPharma Medical Inc | 100.00% |
Evolutionary Genomics Inc | 99.96% |
Entia Biosciences Inc | 99.95% |
Regenerx Biopharmaceuticals Inc | 100.00% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -675.85 |
Beta (5Y) | 45.35 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 6.57K% |
Historical Sharpe Ratio (5Y) | -0.0085 |
Historical Sortino (5Y) | -0.5788 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 97.00% |